✦ LIBER ✦

Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial

✍ Scribed by N. D. Freedman; T. M. Curto; C. Morishima; L. B. Seeff; Z. D. Goodman; E. C. Wright; R. Sinha; J. E. Everhart; the HALT-C Trial Group

Book ID: 108606125
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 214 KB
Volume: 33
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2010.04503.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weight-Related Effects on Disease Progre

✍ James E. Everhart; Anna S. Lok; Hae–Young Kim; Timothy R. Morgan; Karen L. Linds 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Dietary Cholesterol Intake Is Associated

Dietary Cholesterol Intake Is Associated With Progression of Liver Disease in Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial

✍ Yu, Lei; Morishima, Chihiro; Ioannou, George N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Herbal product use by persons enrolled i

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

✍ Leonard B. Seeff; Teresa M. Curto; Gyongyi Szabo; Gregory T. Everson; Herbert L. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 2 views

Herbal products, used for centuries in Far Eastern countries, are gaining popularity in western countries. Surveys indicate that persons with chronic hepatitis C (CHC) often use herbals, especially silymarin (milk thistle extract), hoping to improve the modest response to antiviral therapy and reduc

Hepatic Steatosis in Hepatitis C: Compar

Hepatic Steatosis in Hepatitis C: Comparison of Diabetic and Nondiabetic Patients in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial

✍ Lok, Anna S.F.; Everhart, James E.; Chung, Raymond T.; Padmanabhan, Latha; Green 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Su1026 Statin Use Reduces Risk of Progre

Su1026 Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

✍ Simon, Tracey G.; King, Lindsay Y.; Zheng, Hui; Chung, Raymond T. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 374 KB

HCV RNA detection by TMA during the hepa

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial

✍ Chihiro Morishima; Timothy R. Morgan; James E. Everhart; Elizabeth C. Wright; Mi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

For making treatment decisions related to chronic hepatitis C, the utility of HCV RNA tests with increased sensitivity has not been defined. Prior interferon nonresponders with advanced fibrosis (n ‫؍‬ 1,145) were retreated with peginterferon alpha-2a and ribavirin. Patients who were HCV RNA-negativ